Because of an improved understanding of lung cancer biology and improvement in systemic
treatment, an oligometastatic state in which metastatic disease is present at a limited number …

Purpose Stereotactic body radiation therapy (SBRT) has become the standard of care for
inoperable early-stage non-small cell lung cancer and is often used for recurrent lung …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Non-Small Cell Lung Cancer (NSCLC) focuses on the principles of radiation therapy …

Objectives The current literature on stereotactic body radiotherapy (SBRT) for
oligometastatic disease is characterized by small patient cohorts with heterogeneous …

Local treatment for pulmonary oligometastases (one to five lesions) using metastasectomy
or stereotactic ablative radiotherapy (SABR) was investigated in a cohort that received …

Purpose Stereotactic ablative radiation therapy (SABR) is increasingly used to treat lung
oligometastases. We set out to determine the safety and efficacy of this approach and to …

There are limited data available regarding the management of oligometastatic squamous
cell carcinoma of the head and neck (SCCHN) patients, and no consensus guidelines are …

Aims Lung metastasectomy and, more recently, stereotactic body radiotherapy (SBRT), are
frequently proposed to stage IV oligometastatic colorectal cancer (CRC) patients. In the …

The incidence of lung cancer with intraocular metastasis is low, of which choroidal
metastasis is the most painful metastatic lesion. The clinical symptoms resulting from …

To analyze the impact of SBRT on systemic treatment-free survival in patients affected by
lung oligometastases. Inclusion criteria of the study were (a) KPS> 70,(b) 1–5 lung …